BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9343807)

  • 1. Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means.
    Stinnett AA; Paltiel AD
    Med Decis Making; 1997; 17(4):483-9. PubMed ID: 9343807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portfolio evaluation of health programs: a reply to Sendi et al.
    Bridges JF; Terris DD
    Soc Sci Med; 2004 May; 58(10):1849-51. PubMed ID: 15020002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence.
    Laska EM; Meisner M; Siegel C; Stinnett AA
    Health Econ; 1999 Mar; 8(2):171-4. PubMed ID: 10342730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunity costs and uncertainty in the economic evaluation of health care interventions.
    Sendi P; Gafni A; Birch S
    Health Econ; 2002 Jan; 11(1):23-31. PubMed ID: 11788979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of cost-effectiveness analysis to multiple products: a practical guide.
    Bala MV; Zarkin GA
    Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portfolio theory and the alternative decision rule of cost-effectiveness analysis: theoretical and practical considerations.
    Sendi P; Al MJ; Gafni A; Birch S
    Soc Sci Med; 2004 May; 58(10):1853-5. PubMed ID: 15020003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty.
    Sendi P; Al MJ
    Soc Sci Med; 2003 Sep; 57(6):969-74. PubMed ID: 12878098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interpretation of results of economic evaluation: explicating the value of health.
    Ament A; Baltussen R
    Health Econ; 1997; 6(6):625-35. PubMed ID: 9466144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis and policy choices: investing in health systems.
    Murray CJ; Kreuser J; Whang W
    Bull World Health Organ; 1994; 72(4):663-74. PubMed ID: 7923545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health state utility anchors: being clear on what "1" means.
    O'Brien BJ
    Med Decis Making; 1997; 17(3):352-3. PubMed ID: 9219197
    [No Abstract]   [Full Text] [Related]  

  • 11. Estimating the Bayesian loss function. A conjoint analysis approach.
    Bala MV; Mauskopf J
    Int J Technol Assess Health Care; 2001; 17(1):27-37. PubMed ID: 11329843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of average cost-effective ratios.
    Laska EM; Meisner M; Siegel C
    Health Econ; 1997; 6(5):497-504. PubMed ID: 9353650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the estimation of cost-effectiveness ratios.
    Johannesson M
    Health Policy; 1995 Mar; 31(3):225-9. PubMed ID: 10142618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Decision-analytical modelling of costs per QALY in the context of the German Social Law].
    Rogowski WH; Landauer M; John J
    Gesundheitswesen; 2009 Nov; 71(11):739-50. PubMed ID: 19551622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis.
    Stinnett AA; Mullahy J
    Med Decis Making; 1998; 18(2 Suppl):S68-80. PubMed ID: 9566468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longevity bias in cost-effectiveness analysis.
    Liu L; Rettenmaier AJ; Saving TR
    Health Econ; 2008 Apr; 17(4):523-34. PubMed ID: 17990284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources.
    Sendi P; Al MJ; Gafni A; Birch S
    Soc Sci Med; 2003 Dec; 57(11):2207-15. PubMed ID: 14512250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis for health communication programs.
    Guilkey DK; Hutchinson P; Lance P
    J Health Commun; 2006; 11 Suppl 2():47-67. PubMed ID: 17148099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the possibility of a bridge between CBA and CEA: comments on a paper by Dolan and Edlin.
    Hansen BO; Hougaard JL; Keiding H; Ă˜sterdal LP
    J Health Econ; 2004 Sep; 23(5):887-98. PubMed ID: 15353184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane.
    Sendi PP; Briggs AH
    Health Econ; 2001 Oct; 10(7):675-80. PubMed ID: 11747050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.